Effects of Smoking on Hematological Parameters among Baghdad City
Article Sidebar
Page Numbers:
1095-1109
Digital Object Identifier:
10.58578/ajstea.v3i4.6072
Viewed: 254 times
Downloaded: 151 times
LYAS Publisher cordially invites qualified professionals to serve as Editors or Reviewers. Your expertise will make an important contribution to maintaining and strengthening the academic quality of our publications. Interested applicants are kindly requested to complete the application form at the following link: Editors & Reviewers
Please feel free to contact us if you need any further information about the submission process or if you have any additional questions.
Authors:
Wed Abbas Mohammed1* 
Copyright :
Authors retain copyright and grant the journal right of first publication.
Main Article Content
Abstract
Cigarette smoking is widely recognized as a major risk factor in the development and progression of various chronic diseases, including atherosclerosis and chronic obstructive pulmonary disease. In Iraq, smoking remains prevalent across both rural and urban populations. It has been associated with significant alterations in inflammatory markers and hematological parameters. This study aimed to examine smoking habits and their effects on key blood parameters, including Total Leukocyte Count (TLC), Differential Leukocyte Count, Total Red Blood Cell Count (TRBC), Hemoglobin (Hb) concentration, and Packed Cell Volume (PCV). A total of 80 healthy adult males aged 20 to 56 years from Baghdad were enrolled, comprising 40 smokers and 40 non-smokers. Participant classification was based on a self-administered questionnaire. The results revealed that TLC, TRBC, Hb concentration, PCV, eosinophils, and lymphocytes were elevated in both light and heavy smokers compared to non-smokers, while neutrophil and monocyte levels were reduced. These findings suggest that cigarette smoking induces measurable changes in hematological profiles, which may contribute to its role in disease pathogenesis.
Downloads
Article Details
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
References
Fagerström, K. (2014, December). Nicotine: Pharmacology, toxicity and therapeutic use. Journal of Smoking Cessation, 9(2), 53–59. https://doi.org/10.1017/jsc.2014.27
International Union of Basic and Clinical Pharmacology (IUPHAR). (n.d.). Nicotinic acetylcholine receptors: Introduction. IUPHAR Database. Retrieved September 1, 2014, from https://www.guidetopharmacology.org
Malenka, R. C., Nestler, E. J., & Hyman, S. E. (2009). Autonomic nervous system. In A. Sydor & R. Y. Brown (Eds.), Molecular neuropharmacology: A foundation for clinical neuroscience (2nd ed., p. 234). McGraw-Hill Medical.
Kishioka, S., Kiguchi, N., Kobayashi, Y., & Saika, F. (2014). Nicotine effects and the endogenous opioid system. Journal of Pharmacological Sciences, 125(2), 117–124. https://doi.org/10.1254/jphs.14R03CP
Cunha, O. T., Rego, A. C., & Oliveira, C. R. (2008). Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs. Brain Research Reviews, 58(1), 192–208. https://doi.org/10.1016/j.brainresrev.2008.03.002
Hartmann-Boyce, J., Chepkin, S. C., Ye, W., Bullen, C., & Lancaster, T. (2018, May). Nicotine replacement therapy versus control for smoking cessation. Cochrane Database of Systematic Reviews, 5, CD000146. https://doi.org/10.1002/14651858.CD000146.pub5
England, L. J., Bunnell, R. E., Pechacek, T. F., Tong, V. T., & McAfee, T. A. (2015, August). Nicotine and the developing human: A neglected element in the electronic cigarette debate. American Journal of Preventive Medicine, 49(2), 286–293. https://doi.org/10.1016/j.amepre.2015.01.015
Centers for Disease Control and Prevention. (n.d.). Health effects of cigarette smoking. Retrieved from https://www.cdc.gov/tobacco/data_statistics/fact_sheets/health_effects/effects_cig_smoking/
Gn, C. R., & Rogman, A. (1996). Tobacco methods and instrumentation: A half century forum. Recent Advances in Tobacco Science, 22, 131–304.
Janson, C., Chinn, S., Jarvis, D., Zock, J. P., Torén, K., & Burney, P. (2001). Effect of passive smoking on respiratory symptoms, lung function, and serum IgE: A European study. The Lancet, 358(9299), 2103–2109.
Hussein, M. U., & Ali, A. H. (2019). The effect of mean period and ejection time in patients with hypertension. Research Journal of Biotechnology, 14(Special Issue I), 297–302.
Sheps, D. S., Herbst, M. C., Hinderliter, A. L., Adams, K. F., Ekelund, L. G., & Neil, J. J. (1990). Arrhythmias produced by elevated carboxyhemoglobin in coronary disease. Annals of Internal Medicine, 113(5), 343–351.
Ariens, E., Simonis, A. M., & Offermeir, J. (1976). Introduction to general toxicology. Academic Press.
Sodhi, P. K., Goyal, J. L., & Mehta, D. K. (2001). Methanol-induced optic neuropathy: Treatment with high-dose IV steroids. International Journal of Clinical Practice, 55, 599–602.
Haldane, J. (1985). The action of carbonic oxide on man. The Journal of Physiology, 18(5–6), 430–462.
Narkiewicz, K., Kjeldsen, S. E., & Hedner, T. (2005). Is smoking a causative factor of hypertension? PubMed, 14(2), 69–71.
Vainio, H. (1987). Is passive smoking increasing cancer risk? Scandinavian Journal of Work, Environment & Health, 13(3), 193–196.
Blumenthal, I. (2001). Carbon monoxide poisoning. Journal of the Royal Society of Medicine, 94, 270–272.
Lakshmi, A. S., Lakshmanan, A., Kumar, G. P., & Saravanan, A. (2014). Effect of cigarette smoking intensity on hematological and lipid parameters. Journal of Clinical and Diagnostic Research, 8(7), 11–13.
Yu, G., Phillips, S., Gail, M. H., et al. (2017). The effect of cigarette smoking on oral and nasal microbiota. Microbiome, 5, 3.
Asif, M., Karim, S., Umar, Z., et al. (2013). Effect of cigarette smoking on hematological parameters. Turkish Journal of Biochemistry, 38(1), 75–80.
Helman, N., & Rubenstein, L. S. (1975). Age, sex, and smoking effects on erythrocytes and leukocytes. American Journal of Clinical Pathology, 63(1), 35–44.
Tsiara, S., Elisaf, M., & Mikhailidis, D. P. (2003). Influence of smoking on predictors of vascular disease. Angiology, 54, 507–530.
Geffken, D., Cushman, M., Burke, G. L., Polak, J. F., Sakkinen, P. A., & Tracy, R. P. (2001). Physical activity and inflammation in the elderly. American Journal of Epidemiology, 153, 242–250.
Lewis, S. M., Bain, B. J., & Bates, I. (2006). Practical hematology (10th ed., pp. 1–40). Elsevier.
National Health and Medical Research Council. (2018). Nutrient reference values for Australia and New Zealand.
Brigden, M. L. (1999). Clinical utility of the erythrocyte sedimentation rate. American Family Physician, 60(5), 1443–1450.
Böttiger, L. E., & Svedberg, C. A. (1967). Normal erythrocyte sedimentation rate and age. British Medical Journal, 2(5544), 85–87.
Varol, E., Icli, A., Kocyigit, S., Erdogan, D., Ozaydin, M., & Dogan, A. (2012). Effect of smoking cessation on mean platelet volume. Clinical and Applied Thrombosis/Hemostasis. Advance online publication.
Caponnetto, P., Russo, C., Di Maria, A., et al. (2011). Circulating endothelial coagulative markers after smoking cessation: A 12-month study. European Journal of Clinical Investigation, 41(6), 616–626.
Butkiewicz, A. M., Kemona-Chetnik, I., Dymicka-Piekarska, V., Matowicka-Karna, J., Kemona, H., & Radziwon, P. (2006). Smoking and thrombocytopoiesis in men and women. Advances in Medical Sciences, 51, 123–126.
Arslan, E., Yakar, T., & Yavasoglu, I. (2008). Effect of smoking on mean platelet volume and lipid profile. Anadolu Kardiyoloji Dergisi, 8(6), 422–425.
Ghosh, A., Chowdhury, S. D., & Ghosh, T. (2012). Undernutrition in Nepalese children: Biochemical and hematological study. Acta Paediatrica, 101(6), 671–676.
Can, C., Malkoç, H., Coşkun, H., Küçükoğlu, B., & Özmen, E. (2007). Evaluation of reticulocyte parameters in anemia types. International Journal of Laboratory Hematology, 29(5), 327–334.
Freedman, D. S., Flanders, W. D., Barboriak, J. J., Malarcher, A. M., Gates, L. (1996). Smoking and leukocyte subpopulations in men. Annals of Epidemiology, 6(4), 299–306.
Kawada, T. (2004). Smoking-induced leukocytosis after cessation. Archives of Medical Research, 35, 246–250.
Calapai, G., Caputi, A. P., Mannucci, C., Russo, A. G., Gregg, E., Puntoni, R., et al. (2009). Cardiovascular biomarkers in long-term smokers. Basic & Clinical Pharmacology & Toxicology, 104, 322–328.
Geffken, D., Cushman, M., Burke, G. L., et al. (2001). Physical activity and markers of inflammation. American Journal of Epidemiology, 153, 242–250.
Kume, A., Kume, T., Masuda, K., Shibuya, F., & Yamazaki, H. (2009). Dose-dependent effects of cigarette smoke on biomarkers. Journal of Health Sciences, 55(2), 259–264.
Islam, M. M., Amin, M. R., Begum, S., Akther, D., & Rahman, A. (2007). Total WBC count in adult male smokers. Journal of Bangladesh Society of Physiology, 2, 49–53.
Bain, B. J., Rothwell, M., Feher, M. D., Robinson, R., Brown, J., et al. (1992). Hematological changes on smoking cessation. Journal of the Royal Society of Medicine, 85, 80–82.
Ho, C. H. (2004). WBC and platelet counts influence whole blood viscosity. Journal of the Chinese Medical Association, 67(8), 394–397.
Levenson, A. C., Simon, F. A., Cambien, F., & Beretti, C. (1987). Smoking, hypertension, and blood hyperviscosity. Arteriosclerosis, Thrombosis, and Vascular Biology, 7, 572–577.
Varol, E., Icli, A., Kocyigit, S., Erdogan, D., Ozaydin, M., & Dogan, A. (2012). Effect of smoking cessation on MPV. Clinical and Applied Thrombosis/Hemostasis. Advance online publication.
Caponnetto, P., Russo, C., Di Maria, A., et al. (2011). Circulating coagulative activation markers after smoking cessation. European Journal of Clinical Investigation, 41(6), 616–626.
Butkiewicz, A. M., Kemona-Chetnik, I., Dymicka-Piekarska, V., Matowicka-Karna, J., Kemona, H., & Radziwon, P. (2006). Smoking and platelet activation. Advances in Medical Sciences, 51, 123–126.
Arslan, E., Yakar, T., & Yavasoglu, I. (2008). Smoking and lipid profile in young men. Anadolu Kardiyoloji Dergisi, 8(6), 422–425.
Calapai, G., Caputi, A. P., Mannucci, C., Russo, A. G., Gregg, E., Puntoni, R., et al. (2009). Cardiovascular biomarkers in smokers after a decade. Basic & Clinical Pharmacology & Toxicology, 104, 322–328.